Old Mission Capital’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Old Mission Capital’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,742	Closed	-$4.09K	–	1847
2022 Q4	$4.09K	Buy	+13,742	New	+$2.77K	﹤0.01%	1300
2022 Q3	–	Sell	-14,388	Closed	-$1K	–	1524
2022 Q2	$1K	Buy	14,388 +3,014	+26%	+$510	﹤0.01%	1387
2022 Q1	$2K	Buy	+11,374	New	+$5.32K	﹤0.01%	1315

Old Mission Capital's EBACW Position: Q1 2023 in Review

Old Mission Capital sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 13,742 shares — an estimated $4.09K sold.

Old Mission Capital first reported a position in EBACW in Q1 2022 and held it in 3 quarters. The position peaked at $4.09K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

Old Mission Capital reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Old Mission Capital sold 13,742 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $4.09K.
Old Mission Capital first reported a position in European Biotech Acquisition Corp. Warrant in Q1 2022 and held it in 3 quarters.
Old Mission Capital's European Biotech Acquisition Corp. Warrant position peaked at $4.09K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Old Mission Capital's 13F filing for Q1 2023, filed 12 May 2023.